Company / Return on Equity (ROE)
LifeStance Health Group, Inc. Return on Equity (ROE) History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Return on Equity (ROE)
0.6%
FY2025
5-year range
-19.9% / 0.6%
FY2021-FY2025
Trend
+116.1%
vs FY2024
Sector context
#83 of 147
Health Care
What the data says
At 0.6%, LifeStance Health Group, Inc.'s return on equity (roe) ranks #83 of 147 in the Health Care sector. Return on Equity (ROE) has increased for 4 consecutive years, from -19.9% in FY2021 to 0.6% in FY2025.
Based on SEC 10-K filings.
0.6% in FY2025 with a 5-year CAGR of +2.0%.
Improved from -13.0% to 0.6% over the past 2 years.
Health Care sector context is included.
Return on Equity (ROE) over time
Growth rates
- 3-Year Change
- +14.8pp
- 5-Year Change
- +2.0pp
- 10-Year Change
- -
Sector benchmark
#83 of 147 in Health CareTop 56% of 147This company 0.6% Sector average -3.0%
▼
+121.0% above sector average
Key checks
Key Insights
- LifeStance Health Group, Inc.'s return on equity (roe) has grown for 4 consecutive years.
- In FY2025, return on equity (roe) increased 116.1% year-over-year.
- Currently 3.7pp above the Health Care sector average.
- Lowest return on equity (roe) in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Return on Equity (ROE)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | 0.6% | +116.1% |
| FY2024 | -4.0% | +69.6% |
| FY2023 | -13.0% | +8.1% |
| FY2022 | -14.2% | +28.6% |
| FY2021 | -19.9% | -1406.1% |
| FY2020 | -1.3% | - |
| FY2019 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026